| GWAS |
- Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL) ( 28090653
)
- Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy) ( 31835028
)
- Bipolar disorder ( 34002096
)
- Diastolic blood pressure ( 30224653
)
- Height ( 28552196
)
- Obesity-related traits ( 23251661
)
- Schizophrenia ( 25056061
29483656
)
- White matter hyperintensity burden ( 25663218
)
|
- Body fat percentage ( 31752434
)
- Colonoscopy-negative controls vs population controls ( 29228715
)
- Colorectal cancer ( 29228715
)
- Femur bone mineral density x serum urate levels interaction ( 34046847
)
- FEV1 ( 30804560
)
- Height ( 28552196
31562340
)
- Hip circumference adjusted for BMI ( 28552196
)
- Low density lipoprotein cholesterol levels ( 33339817
)
- Lung function (FEV1) ( 26635082
28166213
)
- Lung function (FEV1/FVC) ( 30804560
26635082
28166213
)
- Lung function (FVC) ( 30804560
)
- Metastatic colorectal cancer survival in treatment with chemotherapy plus biologics ( 32958699
)
- Parkinson's disease or first degree relation to individual with Parkinson's disease ( 31701892
)
- Peak expiratory flow ( 30804560
)
- Physiological traits ( 31902109
)
- QT interval (sulfonylurea treatment interaction) ( 27958378
)
- Systolic blood pressure night-to-day ratio in hypertension ( 29973135
)
- Total cholesterol levels ( 33339817
)
- Urate levels in obese individuals ( 25811787
)
|
